Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex

Author： Anderl Stefanie   Freeland Megan   Kwiatkowski David J.   Goto June  

Publisher： Oxford University Press

ISSN： 1460-2083

Source： Human Molecular Genetics, Vol.20, Iss.23, 2011-12, pp. : 4597-4604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC)

By  

American Journal Of Medical Genetics Part A, Vol. 167, Iss. 9, 2015-09 ,pp. : 2209-2212

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex

By Zeng Ling-Hui   Rensing Nicholas R.   Zhang Bo   Gutmann David H.   Gambello Michael J.   Wong Michael  

Human Molecular Genetics, Vol. 20, Iss. 3, 2011-02 ,pp. : 445-454

Oxford University Press

Access to resources Recommend Favorite

A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma

By Wilson Catherine  

Human Molecular Genetics, Vol. 14, Iss. 13, 2005-07 ,pp. : 1839-1850

Oxford University Press

Access to resources Recommend Favorite

Genetics and Molecular Biology of Tuberous Sclerosis Complex

By  

Current Genomics, Vol. 9, Iss. 7, 2008-11 ,pp. : 475-487

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence for a molecular link between the tuberous sclerosis complex and the Crumbs complex

By Massey-Harroche Dominique   Delgrossi Marie-Hélène   Lane-Guermonprez Lydie   Arsanto Jean-Pierre   Borg Jean-Paul   Billaud Marc   Le Bivic André  

Human Molecular Genetics, Vol. 16, Iss. 5, 2007-03 ,pp. : 529-536

Oxford University Press

Access to resources Recommend Favorite